Suppr超能文献

经导管主动脉瓣置换术无需使用造影剂:一种安全的替代植入技术。

Transcatheter Aortic Valve Replacement Without the Use of Contrast Medium: An Alternative Safe Implantation Technique.

机构信息

Department of Cardiac Surgery, Central Clinic Bad Berka, Robert-Koch Allee 9, 99437 Bad Berka, Germany.

出版信息

J Invasive Cardiol. 2020 Sep;32(9):330-334. doi: 10.25270/jic/20.00050. Epub 2020 May 20.

Abstract

BACKGROUND

New transcatheter equipment and accumulated experience have stimulated further refinements in implantation techniques. We aimed to compare the outcomes of transfemoral transcatheter aortic valve replacement (TF-TAVR) with and without the use of contrast medium (CM) in patients with glomerular filtration rate (GFR) <30 mL/min/1.73 m².

METHODS

This single-center, retrospective study included all patients who underwent TF-TAVR procedure with Edwards Sapien balloon-expandable bioprostheses between September 2017 and September 2018 at the Zentralklinik Bad Berka Germany, and compared outcomes of TF-TAVR with and without the use of CM.

RESULTS

A total of 98 consecutive patients were included in this study; 25 patients underwent TF-TAVR without the use of CM and 73 patients underwent TF-TAVR with the use of CM. Acute kidney injury was significantly higher in patients who received CM (15 patients [20.5%] in the control group vs 1 patient [4%] in the study group; P=.04). Other procedure-related complications were equally distributed between both groups.

CONCLUSION

TF-TAVR without the use of CM can be considered a safe and reproducible alternative technique. Furthermore, it reduced the incidence of postoperative acute kidney injury in patients with GFR <30 mL/min/1.73 m².

摘要

背景

新的经导管设备和积累的经验刺激了植入技术的进一步改进。我们旨在比较在肾小球滤过率(GFR)<30 mL/min/1.73 m²的患者中使用和不使用对比剂(CM)的经股动脉经导管主动脉瓣置换术(TF-TAVR)的结果。

方法

这是一项单中心、回顾性研究,纳入了 2017 年 9 月至 2018 年 9 月期间在德国巴特贝雷克中心医院接受爱德华兹·萨皮恩球囊扩张生物瓣 TF-TAVR 手术的所有患者,并比较了使用和不使用 CM 的 TF-TAVR 结果。

结果

本研究共纳入 98 例连续患者;25 例患者未使用 CM 行 TF-TAVR,73 例患者使用 CM 行 TF-TAVR。接受 CM 的患者急性肾损伤发生率明显更高(对照组 15 例[20.5%],研究组 1 例[4%];P=.04)。两组之间其他与手术相关的并发症发生率相当。

结论

不使用 CM 的 TF-TAVR 可以被认为是一种安全且可重复的替代技术。此外,它降低了 GFR<30 mL/min/1.73 m²的患者术后急性肾损伤的发生率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验